Literature DB >> 17002223

Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.

Yadong Huang1.   

Abstract

Apolipoprotein (apo) E is a multifunctional protein that has central roles in lipid metabolism and neurobiology. It has three common isoforms (apoE2, apoE3 and apoE4) that have different effects on lipid and neuronal homneostasis. Unlike apoE3, tie most common isoform, apoE4 is a major risk factor for Alzheimer's disease (AD). Although the mechanisms underlying the actions of apoE4 in AD pathogenesis are still poorly understood, emerging data strongly suggest that apoE4, with its multiple cellular origins and multiple structural and biophysical properties, contributes to this disease by interacting with different factors through various pathways. Thus, multiple molecular and cellular mechanisms should be considered in developing anti-AD drugs that target apoE4.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002223

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  27 in total

1.  Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons.

Authors:  Jens Brodbeck; Maureen E Balestra; Ann M Saunders; Allen D Roses; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

Review 2.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

3.  C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice.

Authors:  Nga Bien-Ly; Yaisa Andrews-Zwilling; Qin Xu; Aubrey Bernardo; Charles Wang; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

Review 4.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

5.  APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes.

Authors:  Jing Zhao; Mary D Davis; Yuka A Martens; Mitsuru Shinohara; Neill R Graff-Radford; Steven G Younkin; Zbigniew K Wszolek; Takahisa Kanekiyo; Guojun Bu
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

6.  ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis.

Authors:  Xu Liu; Lei Li; Fang Liu; Shuming Deng; Ruixia Zhu; Qu Li; Zhiyi He
Journal:  J Neural Transm (Vienna)       Date:  2011-10-09       Impact factor: 3.575

7.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

Authors:  Trevor D Burt; Brian K Agan; Vincent C Marconi; Weijing He; Hemant Kulkarni; Jeffrey E Mold; Marielle Cavrois; Yadong Huang; Robert W Mahley; Matthew J Dolan; Joseph M McCune; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

8.  GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.

Authors:  Gang Li; Nga Bien-Ly; Yaisa Andrews-Zwilling; Qin Xu; Aubrey Bernardo; Karen Ring; Brian Halabisky; Changhui Deng; Robert W Mahley; Yadong Huang
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

9.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

10.  Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function.

Authors:  Ning Zhong; Gayathri Ramaswamy; Karl H Weisgraber
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.